• Products
  • Suppliers
  • Sourcing Requests
Post Sourcing Request Exhibition
  • Helsinn obtains orphan designation for pracinostat to treat AML pharmaceutical-technology
    January 17, 2018
    Helsinn, a Swiss pharmaceutical group, and MEI Pharma, a US oncology company, have been awarded the title of orphan drug by the European Medicines Agency (EMA)
  • FDA Grants Conatus Orphan Drug Designation for IDN-7314 americanpharmaceuticalreview
    June 27, 2017
    Conatus Pharmaceuticals announced the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to Conatus' drug candidate IDN-7314 for the treatment of primary sclerosing cholangitis (PSC), a disease affecting bile ducts in the liver wh

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194

About Us
About PharmaSources
Terms of Service
Privacy Policy
Event Data Sharing Notice
Intellectual Property
Media Partners
Buy
Search Products
Post Sourcing Requests
Search Suppliers
CAS Search
Sell
Member Application
Advertising
Post Products
EZSourcing
Events
CPHI China
PMEC China
Conferences
Search Events
Help
FAQ
Contact Us
Feedback
PharmaSources Customer Service